Nickolay Voronin

Nickolay Voronin, age 40, is a Pharma and Biotech Senior Research Analyst at IKARIAN CAPITAL, LLC, based in Plano, TX. In this role, he conducts deep fundamental research and analysis across pharmaceutical and biotechnology sectors, supporting investment decisions for the firm’s health-focused fund. His expertise centers on public and private companies within the life sciences industry, contributing to strategic investment selection and portfolio construction with a focus on emerging innovations that promote wellness and sustainable growth.

Voronin’s career has been dedicated to the intersection of scientific discovery and financial analysis, with several years spent in senior research analyst roles within the biotech and healthcare asset class. He leverages his advanced technical background to evaluate companies developing new therapies, diagnostics, and technologies, translating complex scientific developments into actionable investment insights for Ikarian Capital’s clients.

He holds a PhD in Biotechnology (2014), an MBA with a focus on strategy and entrepreneurship (2014), an MS in Biotechnology (2008), and a Bachelor’s in Biology (2006), providing a strong foundation for his analytical work. Voronin is recognized for his rigorous approach and for helping Ikarian Capital identify high-value opportunities in pharma and biotech, supporting the firm’s commitment to advancing health, growth, and longevity through targeted investments.